Published in Medical Letter on the CDC and FDA, July 15th, 2007
CytRx plans to begin its Phase IIb clinical trial in the second half of this year, subject to U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.